Ganglioside GM3-NeuGc is a glycosphingolipid present on the outer side of the plasma membrane of vertebrate cells. It can be used as a tumor-specific antigen and a target for cancer immunotherapy.
CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.